CXCL13 has been proposed as a potential biomarker of activity in SLE and LN [27,28], and CXCL13 and CCL4 were shown to have utility in SLE-related haemolytic anaemia, while their roles in NPSLE remain elusive [29]. Here, CCL4 is linked to systemic lupus erythematosus.